Corrigendum to “Euphpepluone S, a new lathyrane diterpenoid with anti-inflammatory activity from Euphorbia peplus L.” [Phytochem. Lett. 55 2023, 61–66]

IF 1.3 4区生物学 Q4 CHEMISTRY, MEDICINAL

Phytochemistry Letters Pub Date : 2024-08-02 DOI:10.1016/j.phytol.2024.07.016

Shi-Peng Guan , Ying Yang , Mao Sun , Min Cai , Xue-Xue Pu , Jian-Yi Huang , Ping Yi , Lin Liu , Ming-Rui Yuan , Yuan-Yuan Cheng , Ying-Tong Di

引用次数: 0

查看原文本刊更多论文

更正："Euphpepluone S，一种来自 Euphorbia peplus L. 的新的具有抗炎活性的 lathyrane 二萜类化合物" [Phytochem.[Phytochem. Lett.］

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Phytochemistry Letters 生物-生化与分子生物学

CiteScore

3.00

自引率

11.80%

发文量

190

审稿时长

34 days

期刊介绍： Phytochemistry Letters invites rapid communications on all aspects of natural product research including: • Structural elucidation of natural products • Analytical evaluation of herbal medicines • Clinical efficacy, safety and pharmacovigilance of herbal medicines • Natural product biosynthesis • Natural product synthesis and chemical modification • Natural product metabolism • Chemical ecology • Biotechnology • Bioassay-guided isolation • Pharmacognosy • Pharmacology of natural products • Metabolomics • Ethnobotany and traditional usage • Genetics of natural products Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.